Based on the Wall Street analyst consensus for 193 of CH:SBIO’s holdings.
CH:SBIO 12 Month Forecast
Average Price Target
$97.50▲(0.00% Upside)
Based on Wall Street analyst 12-month price targets for 193 of Invesco NASDAQ Biotech UCITS ETF’s holdings in the last 3 months. The average price target is $97.50 with a high forecast of $125.51 and a low forecast of $72.34. The average price target represents a ― change from the last price of ―.
What is CH:SBIO’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 193 of CH:SBIO’s holdings, Invesco NASDAQ Biotech UCITS ETF’s 12-month average price target is $97.50.
Is CH:SBIO a Buy, Sell or Hold?
Invesco NASDAQ Biotech UCITS ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 193 of CH:SBIO’s holdings: 163 rated Buy, 29 rated Hold and 1 rated Sell.
What is Invesco NASDAQ Biotech UCITS ETF’s price target?
The average price target for Invesco NASDAQ Biotech UCITS ETF is $97.50, based on Wall Street analyst 12-month price targets for 193 of CH:SBIO’s holdings, issued in the past 3 months. The highest price target is $125.51 and the lowest is $72.34.
How many holdings does CH:SBIO have?
CH:SBIO holds 268 assets.
How can I buy shares of CH:SBIO?
You can buy shares of CH:SBIO through a brokerage account. Compare brokers on our Best Online Brokers page.